Studies related to their role in the SSc fibrotic process have shown elevated levels of serum IGF-I and IGFBP-3 in SSc patients that correlated with the extent of skin involvement and the presence of pulmonary fibrosis (196). This evidence concerns the gene IGF1 and systemic sclerosis.